Skip Navigation

International Journal of Epidemiology 2005 34(3):509-512; doi:10.1093/ije/dyi110
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Egger, M.
Right arrow Articles by Miotti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egger, M.
Right arrow Articles by Miotti, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2005; all rights reserved.

Editorial

Antiretroviral therapy in resource-poor settings: scaling up inequalities?

Matthias Egger1,*, Andrew Boulle2, Mauro Schechter3 and Paolo Miotti4

1 Institute for Social and Preventive Medicine, University of Berne, Berne, Switzerland
2 School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
3 Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
4 Office of AIDS Research, National Institutes of Health (NIH), Bethesda, USA

* Corresponding author. Institute for Social and Preventive Medicine, University of Berne, Finkenhubelweg 11, CH-3012 Bern, Switzerland. egger@ispm.unibe.ch

The first 150 words of the full text of this article appear below.

Since 1996, the increasingly widespread use of potent antiretroviral therapy (ART), a combination of at least three drugs from different classes, has transformed a fatal infection into a chronic disease that is manageable in most patients.1–3 However, in resource-poor settings in Africa, Asia, and Latin America, where 90% of people with HIV/AIDS live, access to ART has so far been limited to a minority of patients, owing to the high cost of drugs and the lack of an infrastructure capable of delivering ART on a large scale. In recent years, costs of proprietary drugs have fallen and low-cost generic preparations have increasingly become available. Many African countries have qualified for grants from the ‘Global Fund to fight AIDS, Tuberculosis, and Malaria’. Worldwide, the Fund has approved over 1 billion US dollars for programmes against HIV/AIDS.4 On December 1, 2003 (World AIDS Day) WHO launched the ‘3 by 5’ initiative (3 . . . [Full Text of this Article]

Act now and act well

Equitable access?

Multilevel, multisite action research


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
A Boulle and N Ford
Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?
Postgrad. Med. J., May 1, 2008; 84(991): 225 - 227.
[Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
A Boulle and N Ford
Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?
Sex Transm Inf, December 1, 2007; 83(7): 503 - 505.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
The Antiretroviral Therapy in Lower Income Countri
Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
Int. J. Epidemiol., October 1, 2005; 34(5): 979 - 986.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
G. D. Smith
Infection, medical care and inequalities
Int. J. Epidemiol., June 1, 2005; 34(3): 507 - 508.
[Full Text] [PDF]